Early Diagnosis of Breast Cancer-related Lymphedema
1 other identifier
observational
300
1 country
1
Brief Summary
This study will conduct clinical trials to explore the mechanisms behind the development of upper limb lymphedema following breast cancer surgery. The investigators will recruit patients who have undergone breast cancer surgery and utilize Indocyanine Green (ICG) lymphography and Lymphoscintigraphy to identify the locations of lymphatic blockages. Shear Wave Elastography (SWE) will be used to detect changes in tissue limb compliance. DXA body composition analysis will measure the differences in the composition ratios between edematous and normal limbs. In addition, diffusion correlation spectrometry will be employed to monitor changes in deep tissue blood flow, complemented by continuous measurements of limb circumference and other physiological parameters. The study aims to explore the interrelationships among lymphatic circulation, limb circumference, tissue compliance, and tissue blood flow rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2022
CompletedFirst Submitted
Initial submission to the registry
August 28, 2023
CompletedFirst Posted
Study publicly available on registry
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
June 11, 2025
June 1, 2025
4.2 years
August 28, 2023
June 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
circumference
Circumference measurements are taken and recorded at 2 cm intervals from the wrist crease to the armpit on both upper limbs
everyday, through study completion, an average of 1 year
Tissue compliance
Measurements are taken every 5 cm from the wrist crease to the armpit on both upper limbs using ShearWave Elastography
every 1 week, through study completion, an average of 1 year
Lymphoscintigraphy
Golden Standard for diagnosing lymphedema, used for detecting the location of lymphatic circulation blockage
Once at the beginning of the study, and another assessment will be conducted six months later if there is a deterioration in lymphedema
Indocyanine green (ICG) lymphography
Routine examination, used for detecting the type of lymphatic blockage
Once at the beginning of the study, and another assessment will be conducted 3 months later if there is a deterioration in lymphedema
DXA body composition analysis
Using DXA to detect and compare the composition of both limbs at different stages after the onset of lymphedema, including changes in protein, fat, and mineral density
Once at the beginning of the study, and another assessment will be conducted 3 months later if there is a deterioration in lymphedema
Study Arms (1)
mastectomy
Expected to include female patients who are undergoing breast cancer resection surgery or those who have already undergone breast resection surgery for breast cancer.
Interventions
Eligibility Criteria
This study aims to recruit 100 breast cancer patients (those who have previously undergone or are expected to undergo any form of breast resection surgery) for research purposes.
You may qualify if:
- Female patients who are expected to undergo breast cancer resection surgery or have already undergone breast resection surgery for breast cancer.
- Absence of unhealed open wounds or other conditions unsuitable for tactile measurements within the measurement area.
- No severe cognitive or emotional impairments.
- No substance abuse (alcohol or drugs).
- Females aged between 20 and 80, capable of fully complying with the requirements of this study plan.
You may not qualify if:
- Presence of unhealed open wounds or other conditions unsuitable for tactile measurements within the measurement area.
- Upper limb abnormalities in function (including joint mobility and muscle strength).
- Significant cognitive, auditory, or expressive language issues that hinder comprehension and compliance with instructions.
- Lack of assistance for daily measurements.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Veterans General Hospital
Kaohsiung City, 81362, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairperson
Study Record Dates
First Submitted
August 28, 2023
First Posted
September 21, 2023
Study Start
October 24, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 11, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available